EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMAUG00000002603
Gene Symbol: MIF
3 Cross references
217 Possible Orthologues:

Macrophage Stimulating 1 Receptor (C-Met-Related Tyrosine Kinase)

Ensembl ID : ENSMAUG00000017235
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSMAUG00000008249
Gene Symbol: MMP12
1 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSMAUG00000001270
Gene Symbol: MMP13
4 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSMAUG00000018577
Gene Symbol: MMP14
4 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMAUG00000010513
Gene Symbol: MMP2
4 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSMAUG00000011335
Gene Symbol: MMP3
1 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSMAUG00000005800
Gene Symbol: MMP9
4 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSMAUG00000015520
Gene Symbol: MTOR
4 Cross references
214 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSMAUG00000009712
Gene Symbol: MC1R
4 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSMAUG00000006998
Gene Symbol: MC3R
4 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSMAUG00000016776
Gene Symbol: MC4R
4 Cross references
121 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).